Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.07 USD | -0.44% | -1.52% | -6.59% |
Business Summary
Number of employees: 3,401
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Therapies
100.0
%
| 2,096 | 100.0 % | 2,419 | 100.0 % | +15.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
31.9
%
| 684 | 32.6 % | 771 | 31.9 % | +12.72% |
Europe
27.7
%
| 651 | 31.1 % | 669 | 27.7 % | +2.82% |
Rest of World
19.4
%
| 312 | 14.9 % | 468 | 19.4 % | +50.28% |
Latin America
13.7
%
| 267 | 12.7 % | 332 | 13.7 % | +24.60% |
Global
7.4
%
| 182 | 8.7 % | 178 | 7.4 % | -2.47% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 56 | Nov. 30 |
Brian Mueller
DFI | Director of Finance/CFO | 50 | 02-11-30 |
Kevin Eggan
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-04 |
Philip Lo Scalzo
CMP | Compliance Officer | - | 06-12-31 |
Chief Tech/Sci/R&D Officer | - | 08-10-31 | |
C. Guyer
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
Stuart Bunting
CTO | Chief Tech/Sci/R&D Officer | - | 08-10-31 |
Henry Fuchs
CTO | Chief Tech/Sci/R&D Officer | 66 | 09-02-28 |
Director/Board Member | 70 | 05-05-15 | |
Traci McCarty
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 16-01-03 |
Director/Board Member | 70 | 05-05-15 | |
Randy Meier
CHM | Chairman | 65 | 06-12-13 |
Elaine Heron
BRD | Director/Board Member | 76 | 02-06-30 |
V. Lawlis
BRD | Director/Board Member | 72 | 07-05-31 |
May Kin Ho
BRD | Director/Board Member | 71 | 21-02-16 |
Mark Enyedy
BRD | Director/Board Member | 60 | Dec. 26 |
Robert Hombach
BRD | Director/Board Member | 58 | 17-09-28 |
Willard Dere
BRD | Director/Board Member | 70 | 16-07-17 |
Director/Board Member | 66 | 19-07-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 189,775,040 | 188,177,949 ( 99.16 %) | 0 | 99.16 % |
Company contact information
BioMarin Pharmaceutical, Inc.
770 Lindaro Street
94901, San Rafael
+415 506 6700
http://www.biomarin.comGroup companies
Name | Category and Sector |
---|---|
BioMarin International Ltd.
BioMarin International Ltd. BiotechnologyHealth Technology BioMarin International develops and commercializes biopharmaceuticals. The company was founded on June 16, 2011 and is headquartered in Dublin, Ireland. |
Biotechnology
|
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.59% | 17.09B | |
-5.99% | 84.46B | |
+3.95% | 40.85B | |
-26.37% | 27.69B | |
+50.44% | 24.28B | |
-32.37% | 13.67B | |
-10.45% | 11.79B | |
-15.88% | 11.86B | |
-4.34% | 8.07B | |
+0.53% | 7.51B |
- Stock Market
- Equities
- BMRN Stock
- Company BioMarin Pharmaceutical Inc.